These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7517981)

  • 21. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
    Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
    Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice.
    Eum SY; Zuany-Amorim C; Lefort J; Pretolani M; Vargaftig BB
    Br J Pharmacol; 1997 Jan; 120(1):130-6. PubMed ID: 9117088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FK-506 inhibits proliferation and IL-4 messenger RNA production by a T-helper 2 cell line.
    Wang SC; Jordan ML; Tweardy DJ; Wright J; Hoffman RA; Simmons RL
    J Surg Res; 1992 Aug; 53(2):199-202. PubMed ID: 1383612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of FK-506 and cyclosporin A on the proliferation of PHA-stimulated T cells in response to IL-2, IL-4 or IL-6.
    Liu J; Sakane T; Tsunematsu T
    Int Arch Allergy Immunol; 1992; 98(4):293-8. PubMed ID: 1384862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
    Dumont FJ; Ok H; Lin S; Kastner CA; Cryan J; Martin MM; Wiederrecht G; Staruch MJ
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1078-88. PubMed ID: 8786538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin.
    Luo H; Chen H; Daloze P; St-Louis G; Wu J
    Clin Exp Immunol; 1993 Nov; 94(2):371-6. PubMed ID: 8222329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
    de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
    J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology.
    Grassberger M; Baumruker T; Enz A; Hiestand P; Hultsch T; Kalthoff F; Schuler W; Schulz M; Werner FJ; Winiski A; Wolff B; Zenke G
    Br J Dermatol; 1999 Aug; 141(2):264-73. PubMed ID: 10468798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis.
    Staruch MJ; Sigal NH; Dumont FJ
    Int J Immunopharmacol; 1991; 13(6):677-85. PubMed ID: 1721613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of mixed lymphocyte reaction to identify subimmunosuppressive FK-506 levels in mice.
    Ellis RA; Brenner MJ; Mackinnon SE; Myckatyn TM; Hunter DA
    Microsurgery; 2003; 23(3):276-82. PubMed ID: 12833332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
    Duncan JI
    J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin.
    Chaudhri G; Hunt NH; Clark IA; Ceredig R
    Cell Immunol; 1988 Aug; 115(1):204-13. PubMed ID: 3135944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes.
    Moutabarrik A; Nakanishi I; Takahara S; Hachim K; Bengahnem MG; Ramadani B; Ishibashi M; Zaid D
    Transpl Int; 1994; 7 Suppl 1():S552-5. PubMed ID: 11271305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis.
    Kortekaas Krohn I; Callebaut I; Alpizar YA; Steelant B; Van Gerven L; Skov PS; Kasran A; Talavera K; Wouters MM; Ceuppens JL; Seys SF; Hellings PW
    Allergy; 2018 May; 73(5):1084-1093. PubMed ID: 29121401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.